These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10725641)

  • 1. In vitro toxicity of (191)Pt-labeled cisplatin to a human cervical carcinoma cell line (ME-180).
    Areberg J; Johnsson A; Wennerberg J
    Int J Radiat Oncol Biol Phys; 2000 Mar; 46(5):1275-80. PubMed ID: 10725641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carboplatin- and cisplatin-induced potentiation of moderate-dose radiation cytotoxicity in human lung cancer cell lines.
    Groen HJ; Sleijfer S; Meijer C; Kampinga HH; Konings AW; De Vries EG; Mulder NH
    Br J Cancer; 1995 Dec; 72(6):1406-11. PubMed ID: 8519652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitivity to topoisomerase I inhibitors and cisplatin is associated with epidermal growth factor receptor expression in human cervical squamous carcinoma ME180 sublines.
    Ling YH; Donato NJ; Perez-Soler R
    Cancer Chemother Pharmacol; 2001 Jun; 47(6):473-80. PubMed ID: 11459199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiotoxicity of platinum-195m-labeled trans-platinum (II) in mammalian cells.
    Howell RW; Kassis AI; Adelstein SJ; Rao DV; Wright HA; Hamm RN; Turner JE; Sastry KS
    Radiat Res; 1994 Oct; 140(1):55-62. PubMed ID: 7938455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different accumulation of cisplatin, oxaliplatin and JM216 in sensitive and cisplatin-resistant human cervical tumour cells.
    Martelli L; Di Mario F; Ragazzi E; Apostoli P; Leone R; Perego P; Fumagalli G
    Biochem Pharmacol; 2006 Sep; 72(6):693-700. PubMed ID: 16844093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New platinum(II) complexes containing both an O,O'-chelated acetylacetonate ligand and a sulfur ligand in the platinum coordination sphere induce apoptosis in HeLa cervical carcinoma cells.
    Muscella A; Calabriso N; De Pascali SA; Urso L; Ciccarese A; Fanizzi FP; Migoni D; Marsigliante S
    Biochem Pharmacol; 2007 Jun; 74(1):28-40. PubMed ID: 17481588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of platinum drug resistance by the histone deacetylase inhibitor belinostat.
    To KK; Tong WS; Fu LW
    Lung Cancer; 2017 Jan; 103():58-65. PubMed ID: 28024697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of an in vitro chemo-radiation response assay for cervical carcinoma.
    Monk BJ; Burger RA; Parker R; Radany EH; Redpath L; Fruehauf JP
    Gynecol Oncol; 2002 Nov; 87(2):193-9. PubMed ID: 12477451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic effects of ICI 182,780 on the cytotoxicity of cisplatin in cervical carcinoma cell lines.
    García-López P; Rodríguez-Dorantes M; Pérez-Cárdenas E; Cerbón M; Mohar-Betancourt A
    Cancer Chemother Pharmacol; 2004 Jun; 53(6):533-40. PubMed ID: 15138713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of action of an orally administered platinum complex [ammine bis butyrato cyclohexylamine dichloroplatinum (IV) (JM221)] in intrinsically cisplatin-resistant human ovarian carcinoma in vitro.
    McKeage MJ; Abel G; Kelland LR; Harrap KR
    Br J Cancer; 1994 Jan; 69(1):1-7. PubMed ID: 8286188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumoral platinum concentrations in patients treated with repeated low-dose cisplatin as a radiosensitizer.
    Lagrange JL; Bondiau PY; Tessier E; Chauvel P; Renée N; Etienne MC; Milano G
    Int J Cancer; 1996 Nov; 68(4):452-6. PubMed ID: 8945615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent cetuximab, cisplatin, and radiation for squamous cell carcinoma of the head and neck in vitro.
    Zhang N; Erjala K; Kulmala J; Qiu X; Sundvall M; Elenius K; Grénman R
    Radiother Oncol; 2009 Sep; 92(3):388-92. PubMed ID: 19447510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of hyperthermia on the action of cis-diamminedichloroplatinum(II), rhodamine 123(2) [tetrachloroplatinum(II)], rhodamine 123, and potassium tetrachloroplatinate in vitro and in vivo.
    Herman TS; Teicher BA; Chan V; Collins LS; Kaufmann ME; Loh C
    Cancer Res; 1988 May; 48(9):2335-41. PubMed ID: 3356001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment and characterization of an in vitro model of acquired resistance to cisplatin in a human testicular nonseminomatous germ cell line.
    Kelland LR; Mistry P; Abel G; Freidlos F; Loh SY; Roberts JJ; Harrap KR
    Cancer Res; 1992 Apr; 52(7):1710-6. PubMed ID: 1312897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Augmentation of cisplatin cytotoxicity using cytokines on cervical carcinoma cell lines.
    Verma VN; Shenoy CN; Nadkarni JJ
    Cancer Biother Radiopharm; 1996 Dec; 11(6):349-54. PubMed ID: 10851495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular accumulation and DNA platination of two new platinum(II) anticancer compounds based on anthracene derivatives as carrier ligands.
    Marqués-Gallego P; Kalayda GV; Jaehde U; Dulk Hd; Brouwer J; Reedijk J
    J Inorg Biochem; 2009 May; 103(5):791-6. PubMed ID: 19303143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cisplatin cytotoxicity is increased by mifepristone in cervical carcinoma: an in vitro and in vivo study.
    Jurado R; Lopez-Flores A; Alvarez A; García-López P
    Oncol Rep; 2009 Nov; 22(5):1237-45. PubMed ID: 19787245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eugenol Exerts Apoptotic Effect and Modulates the Sensitivity of HeLa Cells to Cisplatin and Radiation.
    Fathy M; Fawzy MA; Hintzsche H; Nikaido T; Dandekar T; Othman EM
    Molecules; 2019 Nov; 24(21):. PubMed ID: 31684176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of Src signaling in the synergistic effect between cisplatin and digoxin on cancer cell viability.
    Pereira DG; Salgado MAR; Rocha SC; Santos HL; Villar JAFP; Contreras RG; Fontes CFL; Barbosa LA; Cortes VF
    J Cell Biochem; 2018 Apr; 119(4):3352-3362. PubMed ID: 29130514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of carrier ligand in platinum resistance of human carcinoma cell lines.
    Schmidt W; Chaney SG
    Cancer Res; 1993 Feb; 53(4):799-805. PubMed ID: 8428361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.